Face Masks for General Public Can Help Contain Virus, Study Says
(Bloomberg) -- Widespread use of face masks could help economies reopen safely from coronavirus lockdowns when combined with continued social distancing and other prevention measures, according to a new study.
The risk of transmission is lower in households and among contacts of infected people when masks are worn, according to the study, published in The Lancet medical journal. For medical professionals in a health-care setting, respirator-type devices provide a higher level of protection than standard surgical masks, the report said.
Researchers reviewed data from 172 studies assessing the effectiveness of masks, distancing, eye protection and other measures in preventing transmission from patients with confirmed or probable Covid-19, Middle East respiratory syndrome or severe acute respiratory syndrome, known as SARS.
“Universal face mask use might enable safe lifting of restrictions in communities seeking to resume normal activities and could protect people in crowded public settings and within households,” Raina MacIntyre, professor of global biosecurity at the University of New South Wales in Sydney, said in a linked comment on the study.
The study was funded in part by the World Health Organization and conducted by researchers at more than a dozen universities, hospitals and other institutions in countries including Canada, the U.S., China and the U.K.
Mask use by the general public has divided health authorities, with countries like Austria, Germany and the Czech Republic taking steps to encourage it. Others, like the U.K., have been more circumspect, in part because of concerns about possible shortages for health-care workers. The researchers called for action to ramp up output worldwide.
They cautioned that there is low certainty to the findings on the benefits of masks for the wider public. Social distancing also plays a key role in preventing transmission, with a 1-meter buffer between people significantly reducing the risk, the researchers said. Every meter beyond that, up to 3 meters, was associated with halving the likelihood of passing on the virus.
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.